Literature DB >> 31652152

Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome.

David C Dale1, Emily Dick2, Merideth Kelley1, Vahagn Makaryan1, Jim Connelly3, Audrey Anna Bolyard2.   

Abstract

PURPOSE OF REVIEW: WHIM syndrome (warts, hypogammaglobulinemia, immunodeficiency, myelokathexis, or WHIMs) is a very rare autosomal dominant immunodeficiency disorder attributable to mutations in CXCR4. We reviewed clinical manifestations in 24 patients in 9 families to expand understanding of this syndrome. RECENT
FINDINGS: Warts, cellulitis and respiratory infections are common in patients with WHIMs. Less commonly these patients have congenital heart disease, human papilloma virus-associated malignancies (cervical and vulvular) and lymphomas. Hearing loss because of recurrent otitis media is another important complication. Treatment with granulocyte colony-stimulating factor is controversial; this review indicates that it is effective to prevent and treat infections based upon long-term observations of patients enrolled in the Severe Chronic Neutropenia International Registry. Understanding the natural history and diversity of this syndrome are important for ongoing clinical trials of novel agents to treat WHIMs.
SUMMARY: WHIM syndrome has diverse manifestations; some features occur consistently in almost all patients, for example, neutropenia, lymphocytopenia and mild hypogammaglobulinemia. However, the clinical consequences are quite variable across patient cohorts and within families. Each complication is important as a cause for morbidity and a source for patient and family concerns.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31652152      PMCID: PMC7241424          DOI: 10.1097/MOH.0000000000000554

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.218


  19 in total

1.  CHRONIC IDIOPATHIC GRANULOCYTOPENIA.

Authors:  C E KRILL; H D SMITH; A M MAUER
Journal:  N Engl J Med       Date:  1964-05-07       Impact factor: 91.245

2.  "MYELOKATHEXIS"--A NEW FORM OF CHRONIC GRANULOCYTOPENIA. REPORT OF A CASE.

Authors:  W W ZUELZER
Journal:  N Engl J Med       Date:  1964-04-02       Impact factor: 91.245

3.  The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome.

Authors:  David C Dale; Audrey Anna Bolyard; Merideth L Kelley; Ernest C Westrup; Vahagn Makaryan; Andrew Aprikyan; Brent Wood; Frank J Hsu
Journal:  Blood       Date:  2011-08-11       Impact factor: 22.113

4.  Plerixafor for the Treatment of WHIM Syndrome.

Authors:  David H McDermott; Diana V Pastrana; Katherine R Calvo; Stefania Pittaluga; Daniel Velez; Elena Cho; Qian Liu; Hugh H Trout; João F Neves; Pamela J Gardner; David A Bianchi; Elizabeth A Blair; Emily M Landon; Susana L Silva; Christopher B Buck; Philip M Murphy
Journal:  N Engl J Med       Date:  2019-01-10       Impact factor: 91.245

5.  Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.

Authors:  Laura Dotta; Lucia Dora Notarangelo; Daniele Moratto; Rajesh Kumar; Fulvio Porta; Annarosa Soresina; Vassilios Lougaris; Alessandro Plebani; C I Edvard Smith; Anna-Carin Norlin; Andrea Cecilia Gòmez Raccio; Eva Bubanska; Patrizia Bertolini; Giovanni Amendola; Marcella Visentini; Massimo Fiorilli; Aldo Venuti; Raffaele Badolato
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-02

6.  WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies.

Authors:  R J Gorlin; B Gelb; G A Diaz; K G Lofsness; M R Pittelkow; J R Fenyk
Journal:  Am J Med Genet       Date:  2000-04-24

7.  The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

Authors:  David H McDermott; Qian Liu; Jean Ulrick; Nana Kwatemaa; Sandra Anaya-O'Brien; Scott R Penzak; Joao Oliveira Filho; Debra A Long Priel; Corin Kelly; Mary Garofalo; Patricia Littel; Martha M Marquesen; Diane Hilligoss; Rosamma Decastro; Thomas A Fleisher; Douglas B Kuhns; Harry L Malech; Philip M Murphy
Journal:  Blood       Date:  2011-09-02       Impact factor: 22.113

8.  Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.

Authors:  Paolo A Hernandez; Robert J Gorlin; John N Lukens; Shoichiro Taniuchi; Joze Bohinjec; Fleur Francois; Mary E Klotman; George A Diaz
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

9.  Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.

Authors:  Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  Expert Opin Orphan Drugs       Date:  2017-09-25       Impact factor: 0.694

Review 10.  Adaptive Immunodeficiency in WHIM Syndrome.

Authors:  Shamik Majumdar; Philip M Murphy
Journal:  Int J Mol Sci       Date:  2018-12-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.